Baskin Financial Services’s POINT Biopharma Global Inc. Common Stock PNT Stock Holding History

Baskin Financial Services’s Portfolio PNT Stock Details PNT Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2023 Q4	–	Sell	-132,990	Closed	-$887K	–	55
2023 Q3	$887K	Hold	132,990	–	–	0.09%	42
2023 Q2	$1.21M	Sell	132,990 -10,500	-7%	-$92.6K	0.12%	41
2023 Q1	$1.04M	Hold	143,490	–	–	0.11%	42
2022 Q4	$1.05M	Hold	143,490	–	–	0.12%	42
2022 Q3	$1.11M	Sell	143,490 -35,872	-20%	-$305K	0.13%	40
2022 Q2	$1.22M	Hold	179,362	–	–	0.13%	42
2022 Q1	$1.43M	Hold	179,362	–	–	0.13%	43
2021 Q4	$1M	Buy	+179,362	New	+$1.35M	0.08%	43

Other funds holding PNT

BTI

Blue Trust Inc Alpharetta, Georgia $9.54B AUM 19.86% 1-Year Est. Return

Baskin Financial Services's PNT Position: Q4 2023 in Review

Baskin Financial Services sold out of POINT Biopharma Global Inc. Common Stock (PNT) in Q4 2023, closing a stake of 132,990 shares — an estimated $887K sold.

Baskin Financial Services first reported a position in PNT in Q4 2021 and held it in 8 quarters. The position peaked at $1.43M in Q1 2022. 1 fund tracked by Wall St. Rank holds PNT as of Q4 2023.

Baskin Financial Services reported no remaining POINT Biopharma Global Inc. Common Stock position as of Q4 2023 after selling out during the quarter.
Baskin Financial Services sold 132,990 POINT Biopharma Global Inc. Common Stock shares in Q4 2023, an estimated $887K.
Baskin Financial Services first reported a position in POINT Biopharma Global Inc. Common Stock in Q4 2021 and held it in 8 quarters.
Baskin Financial Services's POINT Biopharma Global Inc. Common Stock position peaked at $1.43M in Q1 2022.
1 fund tracked by Wall St. Rank held POINT Biopharma Global Inc. Common Stock as of Q4 2023.

Based on Baskin Financial Services's 13F filing for Q4 2023, filed 23 Jan 2024.